Use of antifibrinolytics in orthotopic liver transplantation
β Scribed by R.P Kufner
- Book ID
- 117229003
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 51 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This article reviews the current status and controversies of the 3 commonly used antifibrinolytics-epsilon-aminocaproic acid, tranexamic acid and aprotinin-during liver transplantation. There is no general consensus on how, when or which antifibrinolytics should be used in liver transplantation. Alt
Hemorrhaging continues to be a significant problem in patients undergoing orthotopic liver transplantation (OLT). Massive transfusion has been associated with morbidity and mortality. In addition, the use of large amounts of blood products for OLT can place a huge demand on the blood banking system